The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women

  • Elma Kučukalić-Selimović Clinics for Nuclear Medicine, Clinical Center University of Sarajevo
  • Amina Valjevac Department for Physiology, Faculty of Medicine, University of Sarajevo
  • Almira Hadžović-Džuvo Department for Physiology, Faculty of Medicine, University of Sarajevo
Keywords: procollagen type 1 N-terminal propeptide, postmenopausal females, osteoporosis, bone mineral density

Abstract

The utility of procollagen type 1 N-terminal propeptide (P1NP) in the management of metabolic bone diseases remains a subject of debate since the reference ranges are not rigorously established and fail to account for many of the preanalytical variables. We aimed to establish reference intervals for P1NP level in healthy and osteoporotic postmenopausal females stratified by age, body mass index and menopausal duration. We also aimed to assess the relationship between P1NP and BMD. This cross-sectional study enrolled 183 postmenopausal females who were divided in osteoporosis group (N=93) and control group (N=90) with preserved bone mass based on BMD assessed by DXA. In the osteoporosis group median P1NP was significantly higher (51.7 ng / mL; 95%CI 43.2-53.7) compared to control group (38.9 ng/mL; 95%CI 34.2-43.9)(p<0.01). After controlling for age, BMI and years since menopause, there was significant inverse association between BMD and P1NP at the femoral neck (r=-0.18), total hip (r=-0.207) and lumbar spine (r=-0.236). There was no significant difference in P1NP concentration across quartiles of age in postmenopausal females. P1NP was significantly lower in obese postmenopausal females with preserved bone mass compared to normal weight and overweight females in control and in osteoporosis group.

In conclusion, we showed that P1NP is inversely associated with BMD even after controlling for age, BMI and years since menopause. Although, P1NP is significantly higher in postmenopausal females with osteoporosis compared to postmenopausal females with preserved bone mass its low specificity does not warrant its utility is diagnosing osteoporosis.

Downloads

Download data is not yet available.
The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women
Published
2013-11-20
How to Cite
1.
Kučukalić-Selimović E, Valjevac A, Hadžović-Džuvo A. The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women. Bosn J of Basic Med Sci [Internet]. 2013Nov.20 [cited 2020Aug.15];13(4):259-65. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/2337
Section
Translational and Clinical Research